Agilent Technologies, Merck KGaA, and PerkinElmer Lead with Advanced Analytical and Life Science Solutions
Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Environmental Testing Products Company Evaluation Report" has been added to ResearchAndMarkets.com's offering.The Environmental Testing Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Environmental Testing. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. 360 Quadrants evaluated over 120 companies, of which the Top 15 Environmental Testing Companies were categorized and recognized as the quadrant leaders.The market is experiencing strong growth, driven by stringent environmental regulations, rapid industrialization, and heightened awareness of pollution's health impacts. Governments across the globe are enforcing strict compliance standards for air, water, and soil quality, prompting industries to adopt advanced environmental testing solutions.
Additionally, climate change initiatives and sustainability targets are accelerating the demand for real-time monitoring systems, IoT-enabled sensors, and AI-powered analytics. Rising incidents of soil and water contamination, along with the expansion of renewable energy projects and smart city developments, are further boosting market demand. As both industries and governments place greater emphasis on environmental protection, the need for accurate, efficient, and technology-driven testing solutions continues to grow.The top criteria for product footprint evaluation included the tested material(microbial contamination, organic compounds, heavy metals, residues, and solids). By sample (wastewater or effluent, soil, air, and others, such as fuel and chemicals). By technology (rapid testing, conventional methods). By end user (agriculture & irrigation sector, government institutes, research and academic institutions, healthcare, industries, and forestry & geology).Key Players:Some of the prominent players are Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Waters Corporation (US), Merck KGaA (Germany), and others. These players are increasingly focusing on product launches and enhancements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, sales contracts, and alliances to strengthen their presence in the global market.Top 3 Companies
Agilent Technologies, Inc.Agilent Technologies is a global leader in the life sciences, diagnostics, and applied chemical markets, offering a comprehensive suite of solutions that includes instruments, software, services, and consumables designed to support the entire laboratory workflow. The company operates across three core business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Within the Life Sciences and Applied Markets segment, Agilent provides advanced instrumentation such as liquid chromatography/mass spectrometry (LC/MS), gas chromatography/mass spectrometry (GC/MS), and inductively coupled plasma mass spectrometry (ICP-MS) - key technologies used in environmental testing and related applications.Merck KGaAMerck KGaA is a global science and technology company involved in the development, production, marketing, and distribution of pharmaceuticals, biopharmaceuticals, specialty chemicals, high-performance materials, and life science tools. In 2015, Merck KGaA significantly expanded its footprint in the life sciences sector through the acquisition of Sigma-Aldrich (US).The company is structured into three main business segments: Healthcare (including Merck Serono, Consumer Health, Allergopharma, and Biosimilars), Performance Materials, and Life Science (operated under the Merck Millipore brand). Within the Life Science segment, Merck Millipore offers cutting-edge solutions for PFAS trace analysis, supporting environmental testing and regulatory compliance. Merck KGaA maintains a strong global presence with operations across Europe, North America, Latin America, Asia Pacific, and Africa. Its major subsidiaries include Merck Serono GmbH, Merck Consumer Health Holding GmbH, Merck Selbstmedikation, Merck Chemicals GmbH, and Merck Schuchardt OHG, all headquartered in Germany.PerkinElmerPerkinElmer is a prominent provider of technologies, services, and solutions catering to the diagnostics, life sciences, environmental, industrial, and laboratory sectors. In March 2023, its Life Science and Diagnostics division was spun off into a separate entity named Revvity, allowing the company to streamline its focus. PerkinElmer operates through two main segments: Discovery & Analytical Solutions and Diagnostics. Within the Discovery & Analytical Solutions segment - specifically under the Applied Markets division - PerkinElmer offers a broad range of mass spectrometry instruments used in environmental analysis and other scientific applications. Its customer base includes pharmaceutical and biotech companies, as well as academic and research institutions.Key Topics Covered: 1 Introduction1.1 Market Definition1.2 Inclusions & Exclusions1.3 Market Stakeholders2 Executive Summary3 Market Overview3.1 Introduction3.2 Market Dynamics3.2.1 Drivers3.2.1.1 Rising Technological Innovations in Environmental Testing3.2.1.2 Growing Public Awareness Related to Health Impact of Pollution3.2.1.3 Development of Portable and Real-Time Environmental Monitoring Technologies3.2.1.4 Increased Participation of Government and Regulatory Bodies in Monitoring Environmental Conditions3.2.2 Restraints3.2.2.1 Expensive Consumables and High Maintenance Cost of Mass Spectrometry Instruments3.2.2.2 Technological Limitations in Mass Spectrometry3.2.3 Opportunities3.2.3.1 Increasing Government Focus on Contaminant Detection3.2.3.2 Increased Utilization of Ai-Driven Analytical Tools to Detect Air and Soil Pollution3.2.3.3 Advancements in Environmental Testing Infrastructure3.2.4 Challenges3.2.4.1 Increased Operational Complexity of Mass Spectrometry Products3.2.4.2 Lack of Skilled Professionals3.3 Trends/Disruptions Impacting Customers' Businesses3.4 Value Chain Analysis3.4.1 Research & Product Development3.4.2 Raw Material Procurement and Manufacturing3.4.3 Distribution and Marketing & Sales3.4.4 Post-Sales Services3.5 Supply Chain Analysis3.5.1 Prominent Companies3.5.2 Small and Medium-Sized Enterprises3.5.3 Distributors3.5.4 End-users3.6 Ecosystem Analysis3.6.1 Role in Ecosystem3.7 Technology Analysis3.7.1 Key Technologies3.7.1.1 Mass Spectrometry (Ms)3.7.1.2 Liquid Chromatography-Mass Spectrometry (Lc-Ms)3.7.1.3 Gas Chromatography-Mass Spectrometry (Gc-Ms)3.7.2 Complementary Technologies3.7.2.1 Laboratory Process Automation3.7.2.2 Cloud Computing3.7.3 Adjacent Technologies3.7.3.1 Environmental Sensors3.8 Patent Analysis3.9 Key Conferences & Events, 2025-20263.10 Porter's Five Force Analysis3.10.1 Bargaining Power of Suppliers3.10.2 Bargaining Power of Buyers3.10.3 Threat of New Entrants3.10.4 Threat of Substitutes3.10.5 Intensity of Competitive Rivalry3.11 Unmet Needs3.12 Impact of Gen Ai/Ai on Environmental Testing Products Market3.12.1 Market Potential of Environmental Testing Products3.12.2 Ai Use Cases3.12.3 Key Companies Implementing Ai3.12.4 Future of Ai in Environmental Testing Products Ecosystem4 Competitive Landscape4.1 Overview4.2 Key Player Strategies/Right to Win4.2.1 Overview of Strategies Adopted by Players in Environmental Testing Products Market4.3 Revenue Analysis, 2019-20234.4 Market Share Analysis, 20234.5 Company Valuation and Financial Metrics4.5.1 Company Valuation4.5.2 Financial Metrics4.6 Brand/Product Comparison4.7 Company Evaluation Matrix: Key Players, 20244.7.1 Stars4.7.2 Emerging Leaders4.7.3 Pervasive Players4.7.4 Participants4.7.5 Company Footprint: Key Players, 20244.7.5.1 Company Footprint4.7.5.2 Region Footprint4.7.5.3 Type Footprint4.7.5.4 Technology Footprint4.7.5.5 Application Footprint4.7.5.6 End-User Footprint4.8 Company Evaluation Matrix: Startups/Smes, 20244.8.1 Progressive Companies4.8.2 Responsive Companies4.8.3 Dynamic Companies4.8.4 Starting Blocks4.8.5 Competitive Benchmarking: Startups/Smes, 20244.8.5.1 Detailed List of Key Startups/Smes4.8.5.2 Competitive Benchmarking of Key Startups/Smes4.9 Competitive Scenario4.9.1 Product Launches4.9.2 Deals4.9.3 Expansions5 Company Profiles
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Waters Corporation
Danaher
Bruker
Shimadzu Corporation
Perkinelmer
Jeol Ltd.
Hitachi High-Tech Corporation
Teledyne Technologies Incorporated
Ametek, Inc.
Jasco Corporation
Merck KGaA
Leco Corporation
Analytik Jena GmbH+Co. Kg
Hiden Analytical
Rigaku Holdings Corporation
Youngin Chromass
Scion Instruments
Restek Corporation
Kore Technology
Process Insights, Inc.
Masstech
Advion, Inc.
Skyray Instruments Usa, Inc.
Microsaic
For more information about this report visit https://www.researchandmarkets.com/r/6ukqpp
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Erreur lors de la récupération des données
Connectez-vous pour accéder à votre portefeuille
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
107% earnings growth over 1 year has not materialized into gains for Genuit Group (LON:GEN) shareholders over that period
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. For example, the Genuit Group plc (LON:GEN) share price is down 21% in the last year. That falls noticeably short of the market return of around 23%. At least the damage isn't so bad if you look at the last three years, since the stock is down 7.7% in that time. The falls have accelerated recently, with the share price down 13% in the last three months. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report. If the past week is anything to go by, investor sentiment for Genuit Group isn't positive, so let's see if there's a mismatch between fundamentals and the share price. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the unfortunate twelve months during which the Genuit Group share price fell, it actually saw its earnings per share (EPS) improve by 107%. It's quite possible that growth expectations may have been unreasonable in the past. The divergence between the EPS and the share price is quite notable, during the year. So it's easy to justify a look at some other metrics. Genuit Group's revenue is actually up 5.9% over the last year. Since the fundamental metrics don't readily explain the share price drop, there might be an opportunity if the market has overreacted. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). We know that Genuit Group has improved its bottom line lately, but what does the future have in store? This free report showing analyst forecasts should help you form a view on Genuit Group What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Genuit Group the TSR over the last 1 year was -18%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! A Different Perspective While the broader market gained around 23% in the last year, Genuit Group shareholders lost 18% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 0.6% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 1 warning sign for Genuit Group that you should be aware of. But note: Genuit Group may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Fletcher King Full Year 2025 Earnings: EPS: UK£1.48 (vs UK£0.028 in FY 2024)
Explore Fletcher King's Fair Values from the Community and select yours Fletcher King (LON:FLK) Full Year 2025 Results Key Financial Results Revenue: UK£3.84m (flat on FY 2024). Net income: UK£153.0k (down 46% from FY 2024). Profit margin: 4.0% (down from 7.4% in FY 2024). EPS: UK£1.48. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Fletcher King shares are up 5.6% from a week ago. Risk Analysis We don't want to rain on the parade too much, but we did also find 3 warning signs for Fletcher King (1 is a bit unpleasant!) that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
20 minutes ago
- Wall Street Journal
You Met Grandma at a Keg Party? The Rich Order $100,000 Memoirs for Family Only.
A new generation of wealthy retirees is commissioning their own memoirs. They're not trying to reach the bestseller list. Many of them just want the kids to know how hard they had it. The ghostwritten memoirs can run hundreds of pages and cost up to $100,000. An entire ecosystem of writers and high-end self-publishers has emerged to meet the demand.
